Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Income Statement
Earnings Waterfall
Rhythm Pharmaceuticals Inc
Revenue
|
77.4m
USD
|
Cost of Revenue
|
-9.3m
USD
|
Gross Profit
|
68.1m
USD
|
Operating Expenses
|
-252.5m
USD
|
Operating Income
|
-184.4m
USD
|
Other Expenses
|
-321k
USD
|
Net Income
|
-184.7m
USD
|
Income Statement
Rhythm Pharmaceuticals Inc
Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+675%
|
1
+332%
|
3
+135%
|
5
+47%
|
13
+190%
|
17
+24%
|
24
+42%
|
34
+42%
|
44
+30%
|
62
+42%
|
77
+25%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(5)
|
(7)
|
(9)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+467%
|
1
+476%
|
3
+161%
|
4
+48%
|
12
+225%
|
15
+24%
|
22
+40%
|
30
+41%
|
39
+27%
|
55
+42%
|
68
+24%
|
|
Operating Income | ||||||||||||||||||||||||||||||||
Operating Expenses |
(20)
|
(23)
|
(26)
|
(27)
|
(28)
|
(30)
|
(32)
|
(43)
|
(51)
|
(62)
|
(78)
|
(92)
|
(121)
|
(139)
|
(146)
|
(151)
|
(139)
|
(136)
|
(137)
|
(136)
|
(144)
|
(155)
|
(173)
|
(192)
|
(205)
|
(203)
|
(201)
|
(209)
|
(219)
|
(240)
|
(252)
|
|
Selling, General & Administrative |
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(8)
|
(10)
|
(13)
|
(18)
|
(24)
|
(28)
|
(31)
|
(34)
|
(36)
|
(37)
|
(42)
|
(42)
|
(42)
|
(46)
|
(48)
|
(54)
|
(61)
|
(68)
|
(75)
|
(82)
|
(87)
|
(92)
|
(95)
|
(103)
|
(111)
|
(118)
|
|
Research & Development |
(14)
|
(18)
|
(20)
|
(21)
|
(21)
|
(22)
|
(23)
|
(30)
|
(33)
|
(38)
|
(50)
|
(61)
|
(88)
|
(103)
|
(109)
|
(109)
|
(97)
|
(93)
|
(90)
|
(88)
|
(90)
|
(95)
|
(104)
|
(117)
|
(123)
|
(117)
|
(109)
|
(114)
|
(116)
|
(129)
|
(135)
|
|
Operating Income |
(20)
N/A
|
(23)
-16%
|
(26)
-12%
|
(27)
-4%
|
(28)
-4%
|
(30)
-7%
|
(32)
-9%
|
(43)
-33%
|
(51)
-19%
|
(62)
-21%
|
(78)
-26%
|
(92)
-17%
|
(121)
-32%
|
(139)
-15%
|
(146)
-5%
|
(151)
-3%
|
(139)
+8%
|
(136)
+2%
|
(137)
-1%
|
(136)
+1%
|
(144)
-6%
|
(154)
-7%
|
(170)
-10%
|
(188)
-11%
|
(193)
-2%
|
(188)
+3%
|
(179)
+5%
|
(179)
+0%
|
(181)
-1%
|
(185)
-3%
|
(184)
+0%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
4
|
5
|
6
|
6
|
5
|
5
|
4
|
4
|
3
|
2
|
1
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
1
|
0
|
|
Total Other Income |
(1)
|
(1)
|
0
|
0
|
(0)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
100
|
100
|
100
|
100
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
|
Pre-Tax Income |
(20)
N/A
|
(24)
-16%
|
(26)
-9%
|
(27)
-4%
|
(28)
-4%
|
(32)
-13%
|
(34)
-7%
|
(44)
-30%
|
(51)
-17%
|
(59)
-15%
|
(74)
-25%
|
(87)
-17%
|
(115)
-33%
|
(133)
-16%
|
(141)
-6%
|
(146)
-4%
|
(134)
+8%
|
(132)
+2%
|
(134)
-1%
|
(34)
+75%
|
(43)
-27%
|
(54)
-24%
|
(70)
-30%
|
(188)
-170%
|
(193)
-2%
|
(189)
+2%
|
(181)
+4%
|
(181)
+0%
|
(182)
-1%
|
(185)
-2%
|
(184)
+1%
|
|
Net Income | ||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(22)
|
(17)
|
(8)
|
0
|
22
|
17
|
8
|
0
|
0
|
0
|
(0)
|
(1)
|
|
Income from Continuing Operations |
(20)
|
(24)
|
(26)
|
(27)
|
(28)
|
(32)
|
(34)
|
(44)
|
(51)
|
(59)
|
(74)
|
(87)
|
(115)
|
(133)
|
(141)
|
(146)
|
(134)
|
(132)
|
(134)
|
(56)
|
(60)
|
(62)
|
(70)
|
(166)
|
(176)
|
(181)
|
(181)
|
(181)
|
(182)
|
(186)
|
(185)
|
|
Net Income (Common) |
(23)
N/A
|
(27)
-16%
|
(29)
-9%
|
(30)
-5%
|
(32)
-5%
|
(36)
-13%
|
(38)
-4%
|
(47)
-24%
|
(53)
-14%
|
(59)
-12%
|
(74)
-25%
|
(87)
-17%
|
(115)
-33%
|
(133)
-16%
|
(141)
-6%
|
(146)
-4%
|
(134)
+8%
|
(132)
+2%
|
(134)
-1%
|
(56)
+58%
|
(60)
-8%
|
(62)
-2%
|
(70)
-13%
|
(166)
-139%
|
(176)
-6%
|
(181)
-3%
|
(181)
+0%
|
(181)
+0%
|
(182)
-1%
|
(186)
-2%
|
(185)
+0%
|
|
EPS (Diluted) |
-0.88
N/A
|
-1.03
-17%
|
-1.13
-10%
|
-1.18
-4%
|
-1.24
-5%
|
-1.4
-13%
|
-2.83
-102%
|
-1.7
+40%
|
-1.89
-11%
|
-1.72
+9%
|
-2.39
-39%
|
-2.51
-5%
|
-3.34
-33%
|
-3.86
-16%
|
-3.86
N/A
|
-3.31
+14%
|
-3.04
+8%
|
-2.99
+2%
|
-3.04
-2%
|
-1.15
+62%
|
-1.2
-4%
|
-1.22
-2%
|
-1.4
-15%
|
-3.3
-136%
|
-3.49
-6%
|
-3.53
-1%
|
-3.47
+2%
|
-3.18
+8%
|
-3.2
-1%
|
-3.2
N/A
|
-3.2
N/A
|